China, Nov. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effects of Lu Dangshen Oral Liquid on Acute Exacerbation, Quality of Life and Pulmonary Function in the Stable Stage of Chronic Obstructive Pulmonary Disease'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135630
Registration Time: 2026/10/31
Type: Interventional study
Primary Sponsor: Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=270785
Published by HT Digital Content Services with permission from Health Daily Digest....